π€ OpenMed AI - Platform Update
OpenMed AI has updated its platform. This update includes a redesigned interface.
Key Points:
β’ OpenMed AI has unveiled a new platform interface.
β’ The update focuses on the platform's visual presentation.
π Resources:
β’ OpenMed AI β - Official X account for OpenMed AI.
Image
π‘ AI for Literature Review - Responsible Use in SciSpace
This content covers how AI tools can accelerate literature review processes. It also emphasizes the importance of responsible AI practices to maintain review quality.
Key Points:
β’ AI tools can shorten literature review times from weeks to days.
β’ Review quality and scrutiny remain paramount despite increased speed.
β’ A demonstration shows AI-assisted literature review in SciSpace.
β’ Responsible AI use practices are integrated into the review process.
π Resources:
β’ SciSpace β - Official X account for SciSpace.
Image
π€ Oncology - I-SPY2 Trial Update on Breast Cancer Treatment
An I-SPY2 trial update indicates a new therapeutic combination for early-stage breast cancer. This treatment strategy involves combining immunotherapy drugs with neoadjuvant paclitaxel.
Key Points:
β’ The I-SPY2 trial investigated a combination therapy for early breast cancer.
β’ Cemiplimab (PD-1) and fianlimab (LAG3) were combined with neoadjuvant paclitaxel.
β’ This combination improved pCR (pathologic complete response) rates.
β’ Improvements were observed in triple-negative and hormone receptor-positive (HR+) cases.
π Resources:
β’ JAMA Oncology β - I-SPY2 trial results on breast cancer treatment.
β’ KolPulseAI β - Official X account for KolPulseAI.
β’ Stephen V Liu β - Official X account for Stephen V Liu.
β’ Claudine Isaacs β - Official X account for Claudine Isaacs.
π€ Oncology - INDIBLADE Trial for Bladder Preservation in MIBC
The INDIBLADE trial, a phase 2 study, explored a bladder preservation strategy for muscle-invasive bladder cancer (MIBC). It combined induction immunotherapy with chemoradiotherapy.
Key Points:
β’ The INDIBLADE trial is a phase 2, single-arm, multicenter study.
β’ It investigates a bladder preservation strategy for MIBC.
β’ Induction ipilimumab and nivolumab were followed by chemoradiotherapy.
β’ The study reported long-term bladder-intact outcomes in specific patients.
π Resources:
β’ KolPulseAI β - Official X account for KolPulseAI.
β’ Niklas KlΓΌmper β - Official X account for Niklas KlΓΌmper.
Image
Image
π§ͺ AI in Drug Discovery - Insilico DDD Benchmark
The Insilico Drug Discovery Development (DDD) Benchmark provides a platform for evaluating foundation models in drug discovery. It offers standardized evaluation against proprietary data.
Key Points:
β’ The Insilico DDD Benchmark assesses AI foundation models for drug discovery.
β’ Models are evaluated on clean data and can earn a spot on a leaderboard.
β’ Two evaluation suites are available: Huge Drug Discovery Foundations and Drug Candidate Essentials.
β’ Baselines are derived from proprietary data from programs reaching preclinical stages.
β’ Any model accessible via a chat-completions API can be scored.
π Implementation:
- Submit a model for evaluation on the Insilico DDD Benchmark.
- Choose between a private report or public leaderboard publication.
π Resources:
β’ Insilico Medicine β - Official X account for Insilico Medicine.
Image
β¨ Mental Wellness - Daily Reflection Prompt
This content presents a daily prompt designed for personal reflection and mental check-ins. It encourages users to consider their current state and observations.
Key Points:
β’ The prompt encourages self-reflection as a mental wellness practice.
β’ It asks users to describe their current state and identify existing elements.
β’ This supports daily journaling and mindfulness.
π Resources:
β’ Stoic App β - Official X account for the Stoic app.
Image
π€ Precigenetics - LUMA Chip and Software Suite
Precigenetics offers a hardware component paired with a software suite. The software component of this offering is named LUMA.
Key Points:
β’ Precigenetics provides a specialized chip.
β’ The chip is accompanied by a software suite.
β’ The software suite is identified as LUMA.
π Resources:
β’ Precigenetics β - Official X account for Precigenetics.
βοΈ Support
If you liked reading this report, please star βοΈ this repository and follow me on Github β, π (previously known as Twitter) β to help others discover these resources and regular updates.